Concepedia

Joan B. Erland

JB

Statistics

Publications

15

Citations

1.1K

H-Index

13

Active since

1997

Affiliations

Sarah Cannon(Current)

Tennessee Oncology

Northwest Behavioral Medicine

University of South Carolina Upstate

Texas Oncology

Joan B. Erland is an author at Sarah Cannon specializing in cancer therapeutics, oncology, and medicine.

Top concepts

Publications per year

1997–2005

15

Publications

15

Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer.

John D. Hainsworth, Howard A. Burris, Joan B. Erland et al. · Journal of Clinical Oncology · 1998 · 251 citations

Weekly Docetaxel in the Treatment of Elderly Patients With Advanced Breast Cancer: A Minnie Pearl Cancer Research Network Phase II Trial

John D. Hainsworth, Howard A. Burris, Denise A. Yardley et al. · Journal of Clinical Oncology · 2001 · 150 citations

Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide.

John D. Hainsworth, Joan B. Erland, Leonard Kalman et al. · Journal of Clinical Oncology · 1997 · 134 citations

Carcinoma of unknown primary site: Phase II trials with docetaxel plus cisplatin or carboplatin

F. Anthony Greco, Joan B. Erland, Lisa H. Morrissey et al. · Annals of Oncology · 2000 · 120 citations · Full text

, , +7

Gemcitabine, Carboplatin, and Paclitaxel for Patients With Carcinoma of Unknown Primary Site: A Minnie Pearl Cancer Research Network Study

F. Anthony Greco, Howard A. Burris, Sharlene Litchy et al. · Journal of Clinical Oncology · 2002 · 111 citations

Rows per page

1–5 of 15